BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30348114)

  • 1. ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
    Zeng Z; Yang H; Xiao S
    BMC Cancer; 2018 Oct; 18(1):1020. PubMed ID: 30348114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
    Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
    Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
    Sun W; Wang W; Lei J; Li H; Wu Y
    Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
    Wang YL; Liang RH; Wang CY; Zhang RP; Wu SY; Han X; Zhang GL
    Clin Transl Oncol; 2022 Jan; 24(1):84-92. PubMed ID: 34181232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
    Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
    Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
    Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
    Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
    Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
    J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1.
    Zhang J; Zhang J; Wei Y; Li Q; Wang Q
    Cell Death Dis; 2019 Oct; 10(11):811. PubMed ID: 31649264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.
    Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X
    Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-216a-3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A-mediated YAP signaling.
    Zhao J; Li L; Yang T
    J Cell Physiol; 2020 Dec; 235(12):9718-9728. PubMed ID: 32401366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway.
    Li F; Zhang C; Fu L
    PLoS One; 2019; 14(10):e0218839. PubMed ID: 31596887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACTL6A suppresses p21
    Shrestha S; Adhikary G; Xu W; Kandasamy S; Eckert RL
    Oncogene; 2020 Sep; 39(36):5855-5866. PubMed ID: 32616890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer.
    Wu ZH; Wang XL; Tang HM; Jiang T; Chen J; Lu S; Qiu GQ; Peng ZH; Yan DW
    Oncol Rep; 2014 Jul; 32(1):395-402. PubMed ID: 24840737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAF53a is a potential prognostic biomarker and promotes invasion and epithelial-mesenchymal transition of glioma cells.
    Meng L; Wang X; Liao W; Liu J; Liao Y; He Q
    Oncol Rep; 2017 Dec; 38(6):3327-3334. PubMed ID: 29039584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
    Zhu G; Li X; Guo B; Ke Q; Dong M; Li F
    Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
    Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
    Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
    [No Abstract]   [Full Text] [Related]  

  • 20. Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    Tang X; Zha L; Li H; Liao G; Huang Z; Peng X; Wang Z
    Oncol Rep; 2017 Oct; 38(4):2023-2032. PubMed ID: 28849076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.